Beta-thalassemia primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Beta-thalassemia}} | {{Beta-thalassemia}} | ||
{{CMG}}; {{AE}} {{MHP}} | |||
==Overview== | |||
==Primary Prevention== | |||
Primary prevention strategies are carrier screening, genetic counseling, and prenatal testing to identify at-risk couples and provide appropriate guidance regarding family planning options | Primary prevention strategies are carrier screening, genetic counseling, and prenatal testing to identify at-risk couples and provide appropriate guidance regarding family planning options | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 21:58, 21 August 2023
Beta-thalassemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Beta-thalassemia primary prevention On the Web |
American Roentgen Ray Society Images of Beta-thalassemia primary prevention |
Risk calculators and risk factors for Beta-thalassemia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]
Overview
Primary Prevention
Primary prevention strategies are carrier screening, genetic counseling, and prenatal testing to identify at-risk couples and provide appropriate guidance regarding family planning options